Tumor Imaging

GALLIUM-67 CITRATE AND SESTAMIBI
  • Tumour of Primary Unknown
  • Disease burden (Extend of tumour) with whole body imaging
  • Residual tumour activity post therapy
  • Recurrent tumour activity in the midst of post- surgical/ therapeutic changes
  • Determine sites of biopsy (most metabolic active site)
  • Lymphomas
  • Benign – Sarcoidiosis; Idiopathic lung disease
NEUROENDOCRINE TUMOURS
  • Radiolabelled MIBG (meta-iodo-benzyl-guaindine) and radiolabelled Octreotide for diagnostic imaging and for therapeutic purposes
WELL-DIFFERENTIATED THYROID CARCINOMA
  • Radioiodine has 3 main indications in the postoperative management of patients with thyroid cancer: Ablation of residual thyroid tissue with 131-I
  • Imaging for possible recurrent disease with 123-I or 131-I
  • And treatment of residual or recurrent thyroid cancer with 131-I
  • Chylothroax
Divider Background

  • "Beloved, I wish above all things that thou mayest prosper and be in health, even as thy soul prospereth."

3 John 1Vs2